[go: up one dir, main page]

NO931709D0 - Nukleinsyreamplifisering ved hjelp av to-enzymers, selvunderholdende sekvensreplikasjon - Google Patents

Nukleinsyreamplifisering ved hjelp av to-enzymers, selvunderholdende sekvensreplikasjon

Info

Publication number
NO931709D0
NO931709D0 NO931709A NO931709A NO931709D0 NO 931709 D0 NO931709 D0 NO 931709D0 NO 931709 A NO931709 A NO 931709A NO 931709 A NO931709 A NO 931709A NO 931709 D0 NO931709 D0 NO 931709D0
Authority
NO
Norway
Prior art keywords
enzymers
self
nucleic acid
acid amplification
sequence replication
Prior art date
Application number
NO931709A
Other languages
English (en)
Other versions
NO931709L (no
Inventor
Eoin David Fahy
Deborah Yantis Kwoh
Thomas Raymond Gingeras
Original Assignee
Siska Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siska Diagnostics Inc filed Critical Siska Diagnostics Inc
Publication of NO931709D0 publication Critical patent/NO931709D0/no
Publication of NO931709L publication Critical patent/NO931709L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
NO93931709A 1990-11-13 1993-05-11 Nukleinsyreamplifisering ved hjelp av to-enzymers, selvunderholdende sekvensreplikasjon NO931709L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61268890A 1990-11-13 1990-11-13
PCT/US1991/008488 WO1992008800A1 (en) 1990-11-13 1991-11-13 Nucleic acid amplification by two-enzyme, self-sustained sequence replication

Publications (2)

Publication Number Publication Date
NO931709D0 true NO931709D0 (no) 1993-05-11
NO931709L NO931709L (no) 1993-07-12

Family

ID=24454235

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931709A NO931709L (no) 1990-11-13 1993-05-11 Nukleinsyreamplifisering ved hjelp av to-enzymers, selvunderholdende sekvensreplikasjon

Country Status (13)

Country Link
EP (1) EP0572417A4 (no)
JP (1) JPH06502767A (no)
AU (1) AU9131591A (no)
CA (1) CA2096013A1 (no)
FI (1) FI932144A0 (no)
HU (1) HUT69772A (no)
IE (1) IE913930A1 (no)
IL (1) IL100040A (no)
NO (1) NO931709L (no)
NZ (1) NZ240574A (no)
PT (1) PT99500A (no)
WO (1) WO1992008800A1 (no)
ZA (1) ZA918965B (no)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5673794A (en) * 1992-11-19 1994-06-08 Matthew C. Biery Production of monoclonal recombinant antibodies without the use of hybridomas by (in vitro) spleen fragment culture combined with isothermal self-sustained sequence replication of rna
WO1995015399A1 (en) * 1993-12-01 1995-06-08 Toyo Boseki Kabushiki Kaisha Method of amplifying and detecting target nucleic acid sequence by using thermostable enzymes
US5705366A (en) * 1994-09-15 1998-01-06 Johnson & Johnson Clinical Diagnostics, Inc. Coamplification of target nucleic acids using volume exclusion agent in reaction composition, test kit and test device useful therefor
JPH08131171A (ja) * 1994-11-11 1996-05-28 Asahi Chem Ind Co Ltd 逆転写酵素の安定化組成物
US5763184A (en) 1996-01-30 1998-06-09 Roche Molecular Systems, Inc. Nucleotide sequence variation in the ABO glycosyltransferase gene
AU4515699A (en) * 1998-06-26 2000-01-17 Akzo Nobel N.V. Tagging of rna amplicons generated by transcription-based amplification
JP2001029078A (ja) * 1999-07-16 2001-02-06 Shimadzu Corp Ｒｎａ増幅法
WO2002012263A1 (en) 2000-08-03 2002-02-14 Roche Diagnostics Gmbh Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
US6780588B2 (en) 2001-05-07 2004-08-24 Applera Corporation Methods for the reduction of stutter in microsatellite amplification
US6841349B2 (en) 2001-05-07 2005-01-11 Applera Corporation Applied Biosystems Group Methods for the reduction of stutter in microsatellite amplification
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US9777312B2 (en) 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
WO2003057910A2 (en) 2002-01-08 2003-07-17 Roche Diagnostics Gmbh Use of silica material in an amplification reaction
US7122314B2 (en) 2002-01-30 2006-10-17 Id Biomedical Corporation Methods for detecting vancomycin-resistant microorganisms and compositions therefor
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
DE10240868A1 (de) * 2002-09-04 2004-03-18 Artus Gesellschaft für molekularbiologische Diagnostik und Entwicklung mbH Verbesserte Verfahren zur Synthese von Nukleinsäuren
WO2004067545A1 (en) 2003-01-29 2004-08-12 Roche Diagnostics Gmbh Improved method for bisulfite treatment
JP2004357502A (ja) * 2003-05-30 2004-12-24 Olympus Corp 核酸分子を使用した情報処理方法
US20090232771A1 (en) 2004-07-13 2009-09-17 Takeda Pharmaceutical Company Limited Method of controlling cell functions
EP1632578A1 (en) 2004-09-03 2006-03-08 Roche Diagnostics GmbH DNA decontamination method
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
EP2185726B1 (en) 2007-08-06 2014-01-08 Orion Genomics, LLC Novel single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the igf2 gene
CA2639416C (en) 2007-09-11 2019-12-31 F. Hoffmann-La Roche Ag Diagnostic test for susceptibility to b-raf kinase inhibitors
WO2009059318A2 (en) 2007-11-01 2009-05-07 University Of Iowa Research Foundation Genes and polymorphisms associated with amd
JP5748672B2 (ja) 2009-02-11 2015-07-15 オリオン ゲノミクス エルエルシー Ｉｇｆ２の対立遺伝子特異的な発現を判定するための多型の組み合わせ
WO2011128096A1 (en) 2010-04-16 2011-10-20 Roche Diagnostics Gmbh Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
CA2801468C (en) 2010-06-04 2018-09-04 Chronix Biomedical Prostate cancer associated circulating nucleic acid biomarkers
WO2012040619A2 (en) 2010-09-24 2012-03-29 Massachusetts Eye And Ear Infirmary Methods and compositions for prognosing and/or detecting age-related macular degeneration
WO2012054727A1 (en) 2010-10-22 2012-04-26 Bio-Rad Laboratories, Inc. Reverse transcriptase mixtures with improved storage stability
CN103946395A (zh) 2011-08-31 2014-07-23 霍夫曼-拉罗奇有限公司 用于预测与抗血管发生疗法有关的高血压的风险的方法
RU2014110271A (ru) 2011-08-31 2015-10-10 Ф. Хоффманн-Ля Рош Аг Восприимчивость к ингибиторам ангиогенеза
JP2014534949A (ja) 2011-09-19 2014-12-25 ジェネンテック， インコーポレイテッド Ｃ−ｍｅｔアンタゴニストおよびｂ−ｒａｆアンタゴニストを含む組合せ処置
US20140303008A1 (en) 2011-10-21 2014-10-09 Chronix Biomedical Colorectal cancer associated circulating nucleic acid biomarkers
AU2012342682A1 (en) 2011-11-23 2014-05-22 F. Hoffmann-La Roche Ag Responsiveness to angiogenesis inhibitors
US9115394B2 (en) 2011-12-22 2015-08-25 Roche Molecular Systems, Inc. Methods and reagents for reducing non-specific amplification
HRP20190209T4 (hr) 2013-05-29 2023-09-15 Chronix Biomedical Detekcija i kvantifikacija acelularne dnk darivatelja u krvotoku primatelja presađivanja organa
KR20160138494A (ko) 2014-03-31 2016-12-05 데비오팜 인터네셔날 에스 에이 Fgfr 융합물
WO2016077366A1 (en) 2014-11-10 2016-05-19 Genentec, Inc. Therapeutic and diagnostic methods for il-33-mediated disorders
CN114250274A (zh) 2015-04-24 2022-03-29 阿提拉生物系统公司 利用有限核苷酸组成的引物扩增
PT3385395T (pt) 2015-08-17 2020-05-06 Kura Oncology Inc Métodos de tratamento de doentes com cancro usando inibidores da farnesiltransferase
WO2017184968A1 (en) 2016-04-22 2017-10-26 Kura Oncology, Inc. Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
US11124839B2 (en) 2016-11-03 2021-09-21 Kura Oncology, Inc. Methods of treating cancer patients with farnesyltransferase inhibitors
US9956215B1 (en) 2017-02-21 2018-05-01 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
AU2018225566B2 (en) 2017-02-21 2019-11-07 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
US10806730B2 (en) 2017-08-07 2020-10-20 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
US11291663B2 (en) 2017-08-07 2022-04-05 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
JP7418337B2 (ja) 2018-02-09 2024-01-19 ジェネンテック， インコーポレイテッド マスト細胞媒介性炎症性疾患の治療法及び診断法
KR20210098969A (ko) 2018-11-01 2021-08-11 쿠라 온콜로지, 인크. 파네실트랜스퍼라제 저해제를 사용한 암의 치료 방법
US20220142983A1 (en) 2019-03-01 2022-05-12 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
CA3134825A1 (en) 2019-03-29 2020-10-08 Kura Oncology, Inc. Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors
TW202102218A (zh) 2019-04-01 2021-01-16 美商庫拉腫瘤技術股份有限公司 以法呢基(farnesyl)轉移酶抑制劑治療癌症的方法
US20220305001A1 (en) 2019-05-02 2022-09-29 Kura Oncology, Inc. Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors
EP4118236A1 (en) 2020-03-13 2023-01-18 MedImmune Limited Therapeutic methods for the treatment of subjects with risk alelles in il33
WO2024015331A1 (en) 2022-07-12 2024-01-18 Genentech, Inc. Therapeutic and diagnostic methods for multiple sclerosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800159A (en) * 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
CA1340807C (en) * 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
KR0148265B1 (ko) * 1988-12-16 1998-10-15 에프.지이.엠 헤르만스 자가-지속 서열 복제 시스템
FI911152A7 (fi) * 1989-07-11 1991-03-07 Gen Probe Inc Nukleiinihapposekvenssin amplifikaatiomenetelmät

Also Published As

Publication number Publication date
HUT69772A (en) 1995-09-28
EP0572417A4 (en) 1994-11-23
PT99500A (pt) 1992-10-30
JPH06502767A (ja) 1994-03-31
IL100040A (en) 1995-12-31
HU9301369D0 (en) 1993-10-28
NO931709L (no) 1993-07-12
CA2096013A1 (en) 1992-05-14
NZ240574A (en) 1994-10-26
AU9131591A (en) 1992-06-11
WO1992008800A1 (en) 1992-05-29
ZA918965B (en) 1992-08-26
FI932144A7 (fi) 1993-05-12
IL100040A0 (en) 1992-08-18
EP0572417A1 (en) 1993-12-08
IE913930A1 (en) 1992-06-17
FI932144L (fi) 1993-05-12
FI932144A0 (fi) 1993-05-12

Similar Documents

Publication Publication Date Title
NO931709D0 (no) Nukleinsyreamplifisering ved hjelp av to-enzymers, selvunderholdende sekvensreplikasjon
DE3884094D1 (de) Kinderwagen.
FI880428A0 (fi) Ytantigener av hepatit b virus och hybridantigener innehaollande desamma.
NO904634L (no) Amplifikasjon av nukleinsyre ved anvendelse av ligerbare,haarnaalsprobe og transkripsjon.
DE3879627D1 (de) Huellkurvenverstaerker.
FI882173L (fi) Syntetisk peptidantigen foer faststaellande av hiv-2 smitta.
FI913236L (fi) 9-purinylfosfonsyraderivat.
FI885625L (fi) Anordning foer automatisering av framstaellning av belaeggning till madrasskropp.
FI884889L (fi) Foerfarande foer framstaellning av en sammansaettning av amfotericin b och kolesterolsulfat.
FI880383A7 (fi) Transformation och expression av en fraemmande gen i brassicaarter.
FI885504L (fi) Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning.
FI885735L (fi) System foer godstransport, vilka aer transformerbara till jaernvaegsfordon och med systemet anvaendbara boggier.
FI913678A0 (fi) Anordning foer modulering av avsoekningshastigheten, vilken anordning aer foersedd med en spaerrkrets.
FI883352L (fi) Anvaendning av dubbelstraengad rna foer framstaellning av ett laekemedel foer behandling av inflammationer.
FI895593A7 (fi) Anordning i synnerhet foer behandling av kraemer och pastor.
FI890874L (fi) Expression av hiv-bindningsproteiner.
FI883005L (fi) Promotorer foer expression av fraemmande dna i metylotrofiska bakterier, deras tillvaratagande och deras anvaendning.
FI881434A0 (fi) Foerfarande foer framstaellning av imidazopyridinderivat vilka aer terapeutiskt anvaendbara.
FI885707A0 (fi) Foerfarande foer frihaollning av genomstroemningskanalen till en staonggjutmaskins glidlucka.
FI890116L (fi) Icke-reverterande rna-virus.
FI902082A0 (fi) Stereoselektiv framstaellning av 3-substituerade 4-anilinopiperidinfoereningar och derivat.
FI882634A0 (fi) Pressvals, vars boejning aer instaellbar.
DE3850923D1 (de) Operationsverstärkerstufen.
NO882048D0 (no) Stillas.
DE3871021D1 (de) Heizapparat.